These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16112273)

  • 81. Structural basis of interleukin-5 dimer recognition by its α receptor.
    Kusano S; Kukimoto-Niino M; Hino N; Ohsawa N; Ikutani M; Takaki S; Sakamoto K; Hara-Yokoyama M; Shirouzu M; Takatsu K; Yokoyama S
    Protein Sci; 2012 Jun; 21(6):850-64. PubMed ID: 22528658
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Interleukin-5: a drug target for allergic diseases.
    Sanderson CJ; Urwin D
    Curr Opin Investig Drugs; 2000 Dec; 1(4):435-41. PubMed ID: 11249696
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Reconstitution of the functional interleukin-5 receptor: the cytoplasmic domain of alpha-subunit plays an important role in growth signal transduction.
    Takaki S; Takatsu K
    Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):36-8. PubMed ID: 8156002
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Monomeric isomers of human interleukin 5 show that 1:1 receptor recruitment is sufficient for function.
    Li J; Cook R; Doyle ML; Hensley P; McNulty DE; Chaiken I
    Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6694-9. PubMed ID: 9192627
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Defining the regions of human interleukin-5 important in receptor binding and cellular activation.
    Wells TN; Graber P; McKinnon M; Banks M; Fattah D; Solari R; Peitsch MC; Proudfoot AE
    Ann N Y Acad Sci; 1996 Oct; 796():226-34. PubMed ID: 8906230
    [No Abstract]   [Full Text] [Related]  

  • 86. The cytokine interleukin-5 (IL-5) effects cotransport of its receptor subunits to the nucleus in vitro.
    Jans DA; Briggs LJ; Gustin SE; Jans P; Ford S; Young IG
    FEBS Lett; 1997 Jun; 410(2-3):368-72. PubMed ID: 9237664
    [TBL] [Abstract][Full Text] [Related]  

  • 87. IL-9 in allergic inflammation.
    Hauber HP; Bergeron C; Hamid Q
    Int Arch Allergy Immunol; 2004 May; 134(1):79-87. PubMed ID: 15133304
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Mutagenesis in the C-terminal region of human interleukin 5 reveals a central patch for receptor alpha chain recognition.
    Morton T; Li J; Cook R; Chaiken I
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10879-83. PubMed ID: 7479902
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Epitope randomization redefines the functional role of glutamic acid 110 in interleukin-5 receptor activation.
    Wu SJ; Tambyraja R; Zhang W; Zahn S; Godillot AP; Chaiken I
    J Biol Chem; 2000 Mar; 275(10):7351-8. PubMed ID: 10702307
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Full house: 12 receptors for 27 cytokines.
    Kotenko SV; Langer JA
    Int Immunopharmacol; 2004 May; 4(5):593-608. PubMed ID: 15120645
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Interleukin 2 receptor--the structure, function and clinical significance in malignant diseases of adults and children].
    Bień E; Balcerska A
    Postepy Hig Med Dosw; 2003; 57(6):669-83. PubMed ID: 15002163
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Structure of interleukin-10/interleukin-10R1 complex: a paradigm for class 2 cytokine activation.
    Walter MR
    Immunol Res; 2002; 26(1-3):303-8. PubMed ID: 12403368
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Spatial orientation of the alpha and betac receptor chain binding sites on monomeric human interleukin-5 constructs.
    Edgerton MD; Graber P; Willard D; Consler T; McKinnon M; Uings I; Arod CY; Borlat F; Fish R; Peitsch MC; Wells TN; Proudfoot AE
    J Biol Chem; 1997 Aug; 272(33):20611-8. PubMed ID: 9252376
    [TBL] [Abstract][Full Text] [Related]  

  • 94. An interleukin 5 mutant distinguishes between two functional responses in human eosinophils.
    McKinnon M; Page K; Uings IJ; Banks M; Fattah D; Proudfoot AE; Graber P; Arod C; Fish R; Wells TN; Solari R
    J Exp Med; 1997 Jul; 186(1):121-9. PubMed ID: 9207003
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Charged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin-12.
    Yoon C; Johnston SC; Tang J; Stahl M; Tobin JF; Somers WS
    EMBO J; 2000 Jul; 19(14):3530-41. PubMed ID: 10899108
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Analysis of three human interleukin 5 structures suggests a possible receptor binding mechanism.
    Verschelde JL; Ampe C; Guisez Y; Oefner C; Vandekerckhove J; Tavernier J
    FEBS Lett; 1998 Mar; 424(3):121-6. PubMed ID: 9539134
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Binding interactions of human interleukin 5 with its receptor alpha subunit. Large scale production, structural, and functional studies of Drosophila-expressed recombinant proteins.
    Johanson K; Appelbaum E; Doyle M; Hensley P; Zhao B; Abdel-Meguid SS; Young P; Cook R; Carr S; Matico R
    J Biol Chem; 1995 Apr; 270(16):9459-71. PubMed ID: 7721873
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Structural analysis and modeling of a synthetic interleukin-2 mimetic and its interleukin-2Rbeta2 receptor.
    Rose T; Moreau JL; Eckenberg R; Thèze J
    J Biol Chem; 2003 Jun; 278(25):22868-76. PubMed ID: 12676936
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Interleukin 5 and allergy].
    Takatsu K
    Arerugi; 1994 Oct; 43(10):1229-39. PubMed ID: 7826218
    [No Abstract]   [Full Text] [Related]  

  • 100. Interleukin-5 and its receptor: a drug target for eosinophilia associated with chronic allergic disease.
    Devos R; Plaetinck G; Cornelis S; Guisez Y; Van der Heyden J; Tavernier J
    J Leukoc Biol; 1995 Jun; 57(6):813-9. PubMed ID: 7790761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.